Only 1 of 26 mice with fewer than 6% circulating CD4+ T cells remained tumor free until sacrifice at day 120, compared with all 19 mice with more than 6% CD4+ T cells (Figure 2C). The gene discussed is CD4; the disease is neoplasm.